Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Paclitaxel, Cyclophosphamide, and Doxorubicin in High-Risk Breast Cancer
NCT00007904Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jul 2000
- Primary completion
- Jun 2006
- Modality
- Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, cyclophosphamide in breast cancer, sponsored by Case Comprehensive Cancer Center. Started Jul 2000; status: completed.
02
Drugs
Paclitaxel Micelles for Injectioncyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00007904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007904.